Malignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamide

Yilmaz, N.Emmungil, H.Gucenmez, S.Ozen, G.Yildiz, F.Balkarli, A.Kimyon, G.2020-03-262020-03-2620150392-856X1593-098Xhttps://hdl.handle.net/20.500.12395/3231011th International Congress on Systemic Lupus Erythematosus -- SEP 02-06, 2015 -- Vienna, AUSTRIA[Abstract not Available]eninfo:eu-repo/semantics/closedAccessMalignancy risk in systemic Lupus Erythematosus patients treated with cyclophosphamideConference Object333S67S67WOS:000360421900240Q2